Atrium Health — Charlotte, North Carolina

Public research footprint of Atrium Health, compiled from the ClinicalTrials.gov public registry.

488

Registered studies

309

Active

160

Recruiting now

118

Completed

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · Recurrent Ovarian Carcinoma · Breast Cancer

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)
NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Atrium Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.